CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α

Ítems similars

• Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
  per: Butterfield, Lisa H., et al.
  Publicat: (2019)
• New approaches to the development of adenoviral dendritic cell vaccines in melanoma
  per: Butterfield, Lisa H, et al.
  Publicat: (2010)
• IFN-α in the Treatment of Melanoma
  per: Tarhini, Ahmad A., et al.
  Publicat: (2012)
• Adenovirus MART-1–engineered Autologous Dendritic Cell Vaccine for Metastatic Melanoma
  per: Butterfield, Lisa H., et al.
  Publicat: (2008)
• Differing Patterns of Circulating Regulatory T-Cells and Myeloid Derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Agonist and GM-CSF with Peptide Vaccination
  per: Tarhini, Ahmad A, et al.
  Publicat: (2012)